Oxygesic Akut (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxygesic Akut, is an opioid analgesic presented as an oral tablet for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxygesic Akut as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides rapid analgesia after surgical procedures. - Cancer‑related pain: helps control moderate to severe malignant pain. - Severe chronic non‑cancer pain: reduces persistent pain when alternative therapies have failed.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness. - Opioid dependence or addiction: compulsive use despite harmful consequences. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Seizures: rare occurrence of convulsive episodes.

Before prescribing Oxygesic Akut, clinicians should evaluate patient risk factors and monitor for adverse events. - Assess pain severity and opioid suitability: ensure opioid therapy is appropriate for the clinical situation. - Monitor respiratory function: watch for signs of respiratory depression, especially after dose changes. - Avoid use in severe respiratory disease: contraindicated in patients with uncontrolled asthma or COPD. - Counsel on constipation risk: advise prophylactic laxatives and adequate hydration. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Oxygesic Akut can interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid): - Other opioids: additive risk of respiratory depression and profound sedation. - Benzodiazepines: synergistic central nervous system depression leading to profound sedation. - Monoamine oxidase inhibitors (MAOIs): may cause severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): increase oxycodone plasma concentrations. - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce oxycodone effectiveness. - Alcohol: enhances sedative effects and may worsen respiratory depression.